Formulation

Formulation and Analytics Platforms Transforming Drug Product Development

David Alvaro, Ph.D.

Pharma's Almanac

Platforms

Built for Speed and Scale: How CDMO Cell Line Platforms Are Reshaping Biologic Development

David Alvaro, Ph.D.

Pharma's Almanac

Biomanufacturing

What are the most significant manufacturing hurdles in biopharma and how can they be addressed?

Pharma's Almanac

Health Equity

How is the pharmaceutical industry addressing global health inequities?

Pharma's Almanac

Next-Gen Biologics

What do you see as the next big modality in biologics, and what factors are driving innovation in this space?

Pharma's Almanac

Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

Leadership

Q: What’s the key to being a leader in the industry?

Pharma's Almanac

Milestones

Q: What important company milestone do you anticipate reaching in 2022?

Pharma's Almanac